Sign up for free insights newsletter
PR

Perrigo Company PLC

PRGOUnited States

Need professional-grade analysis? Visit stockanalysis.com

$9.64
+4.22%
End of day
Market Cap

$1.32B

P/E Ratio

N/A

Employees

N/A

Dividend Yield

1212.00%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-1.02-1.31-1.81-1.59-1.60-1.56
Calmar-11.49-2.73-1.95-1.36-0.95-2.20
Sharpe-0.64-1.35-1.54-1.45-1.39-1.38
Omega0.610.260.590.570.670.57
Martin-18.26-4.22-5.37-2.35-1.93-4.12
Ulcer4.3723.5314.1533.6132.6726.11

Perrigo Company PLC (PRGO) Price Performance

Perrigo Company PLC (PRGO) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $9.64, up 4.22% from the previous close.

Over the past year, PRGO has traded between a low of $9.25 and a high of $27.48. The stock has lost 63.1% over this period. It is currently 64.9% below its 52-week high.

Perrigo Company PLC has a market capitalization of $1.32B and a dividend yield of 1212.00%.

About Perrigo Company PLC

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Company Info

Exchange
United States
Currency
USD

Financial Metrics

Revenue (TTM)
$4.25B
EBITDA
$679.70M
Profit Margin
-33.51%
EPS (TTM)
-10.12
Book Value
21.33

Technical Indicators

52 Week High
$27.49
52 Week Low
$9.23
50 Day MA
$13.69
200 Day MA
$19.15
Beta
0.41

Valuation

Trailing P/E
N/A
Forward P/E
3.95
Price/Sales
0.31
Price/Book
0.45
Enterprise Value
$4.64B